These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3267370)

  • 1. Regulatory hierarchies.
    Oldham RK
    Mol Biother; 1988; 1(1):3-6. PubMed ID: 3267370
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA's compassion for desperate drug companies.
    Annas GJ
    Hastings Cent Rep; 1990; 20(1):35-7. PubMed ID: 2179165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA approves AIDS drug.
    Am Pharm; 1992 Sep; NS32(9):13-4. PubMed ID: 1332462
    [No Abstract]   [Full Text] [Related]  

  • 4. The fast track toward new AIDS drugs.
    Long K; Long R
    Nurse Pract Forum; 1991 Jun; 2(2):80-1. PubMed ID: 1840952
    [No Abstract]   [Full Text] [Related]  

  • 5. Overhaul at the FDA begins.
    Science; 1992 Apr; 256(5055):313. PubMed ID: 1566081
    [No Abstract]   [Full Text] [Related]  

  • 6. DdI approval offers second chance.
    Albert SG
    Am Pharm; 1991 Dec; NS31(12):6. PubMed ID: 1763779
    [No Abstract]   [Full Text] [Related]  

  • 7. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
    Dunbar MM
    Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk versus risk: decision-making dilemmas of drug regulation in the United States and Germany.
    Daemmrich A; Krucken G
    Sci Cult (Lond); 2000 Dec; 9(4):505-34. PubMed ID: 15988846
    [No Abstract]   [Full Text] [Related]  

  • 9. Executive summary from the final reports of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS.
    Oncology (Williston Park); 1991 Apr; 5(4):16, 18-9. PubMed ID: 1831034
    [No Abstract]   [Full Text] [Related]  

  • 10. The FDA's response to AIDS: paradigm shift in new drug policy?
    Podraza R
    Food Drug Law J; 1993; 48(3):351-75. PubMed ID: 11653267
    [No Abstract]   [Full Text] [Related]  

  • 11. What does R&D really cost?
    Huff B
    GMHC Treat Issues; 2001; 15(7-8):1-7. PubMed ID: 11548507
    [No Abstract]   [Full Text] [Related]  

  • 12. A shot in the arm for an AIDS vaccine.
    Newsweek; 1998 Jun; 131(24):62. PubMed ID: 10180631
    [No Abstract]   [Full Text] [Related]  

  • 13. Getting new drugs to people with AIDS: a public policy response to Lansdale.
    Cohen MN
    Hastings Constit Law Q; 1991; 18(3):471-85. PubMed ID: 11651493
    [No Abstract]   [Full Text] [Related]  

  • 14. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
    Schultheis LW; Rappaport BA
    Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS drugs in development. Facts and comparisons.
    Hosp Pharm; 1993 Feb; 28(2):161, 165-7. PubMed ID: 10125704
    [No Abstract]   [Full Text] [Related]  

  • 16. New drug initiatives announced.
    Ann Pharmacother; 1992 Jun; 26(6):868. PubMed ID: 1611177
    [No Abstract]   [Full Text] [Related]  

  • 17. When science and passion meet: the impact of AIDS on research.
    Pripstein J
    CMAJ; 1993 Feb; 148(4):638-42. PubMed ID: 8431829
    [No Abstract]   [Full Text] [Related]  

  • 18. The fast track: federal agencies and the political demand for AIDS drugs.
    Foreman CH
    Brookings Rev; 1991; 9(2):30-7. PubMed ID: 10110828
    [No Abstract]   [Full Text] [Related]  

  • 19. Considering experimentation and elusive truth: informed consent made difficult.
    Brodeur D
    Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS drugs in research.
    Hosp Pharm; 1990 Jun; 25(6):572-3, 576. PubMed ID: 10104831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.